Weill Cornell Medicine scientists target some of the most formidable health challenges of the 21st century, including cancer, cardiovascular disease, metabolic diseases, neurodegenerative diseases such as Parkinson’s and Alzheimer’s, diseases affecting children, and infectious diseases, especially those with significant impact on the developing world.
Dr. Randy Longman (Associate Professor of Medicine) was elected to the American Society for Clinical Investigation (ASCI). His seminal work focuses on defining the cellular, molecular, and microbial regulation of intestinal barrier immunity.
